Welcome to Scholar Publishing Group

International Journal of Public Health and Preventive Medicine, 2023, 4(1); doi: 10.38007/IJPHPM.2023.040102.

Treatment of Polycystic Ovary Syndrome by Liver and Spleen Based Browning of white Adipose


Jinyuan Zhang and Xinchun Xiao

Corresponding Author:
Xinchun Xiao

The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China


Polycystic ovary syndrome (PCOS) is a major disease causing modern women's metabolic disorders, irregular menstruation, infertility, and other symptoms. In addition, the etiology and pathology of PCOS is still not thoroughly studied, so it has become a difficult and complicated disease endangering women's health. Obesity is one of its typical manifestations, and patients often present central obesity. With the in-depth study of modern medicine, people find that obesity plays an important role in regulating the immune inflammatory response and metabolism of the human body, and the change in the distribution ratio of white fat and brown fat in the patient is the root cause of a series of metabolic disorders. At the same time, the role of the two fats in the human body is similar to that of spleen and kidney in many aspects. Coupled with a growing number of experimental studies prove that polycystic ovary syndrome patients lose weight of significant effect on the disease rehabilitation, this paper aims to explore the white fat brown and the relationship between the TCM spleen and kidney, in order to find more effective traditional Chinese and western medicine treatment for polycystic ovary syndrome.


White Adipose Tissue, Brown Adipose Tissue, Spleen, Renal, Polycystic Ovary Syndrome.

Cite This Paper

Jinyuan Zhang and Xinchun Xiao. Treatment of Polycystic Ovary Syndrome by Liver and Spleen Based Browning of white Adipose. International Journal of Public Health and Preventive Medicine (2023), Vol. 4, Issue 1: 9-17. https://doi.org/10.38007/IJPHPM.2023.040102.


[1] Zhang, L.L., Su, X.P., Zhu, L.H., Zhang, X.P., Li, L.R. (2021) Obesity and Health Related Research Progress of Traditional Chinese Medicine. The World of Traditional Chinese Medicine, 1-13. 

[2] Wang, W.Y., Chen, R., Liang, F.X. Discussion on the Theory of Banxia Xiexin Decoction in Treating Insulin Resistant Obesity. World of Traditional Chinese Medicine, 201, 16(20):3054-3057. DOI:10.3969/j.issn.1673-7202.2021.20.016

[3] Yu, Z.W., Lu, M.J., Wang, Y.T., Xu, B. Mechanism of Bidirectional Regulation between Brown Adipose Tissue and Sympathetic Nervous System. Life Science, 201, 33(10):1197-1205. 

[4] Wang, H.N., Qi, Z., Li, X.L., Xiang, J.Z. Advances in Bioactive Substances and Mechanisms That Regulate the Browning of White Fat. Advances in Physiological Science, 201, 52(04):317-322. DOI:10.3969/j.issn.0559-7765.2021.04.015

[5] Wibmer, A.G., Becher, T., Eljalby, M., Crane, A., Andrieu, P.C., Jiang, C.S., Vaughan, R., Schoder, H., Cohen, P. (2021) Brown Adipose Tissue is Associated with Healthier Body Fat Distribution and Metabolic Benefits Independent of Regional Adiposity. Cell Reports Medicine.

[6] Chen, H.Y., Zhou, H.M., Hu, X. Study on Medication Regularity of TCM in the Treatment of Obesity Based on Data Mining. Gansu Science and Technology, 201, 37(12):122-124+63. DOI:10.3969/j.issn.1000-0952.2021.12.040

[7] Yue, H.Q, Zhou, H.D. Study on the Role of White Adipose Tissue in Different Types of Obesity and Metabolic Status. Chinese Journal of Clinical Pathology, 201, 41(06):1448-1453.

[8] Yuko, O.O., Saito, M. (2021) Brown Fat as a Regulator of Systemic Metabolism beyond Thermogenesis. Diabetes & metabolism journal (6). DOI:10.4093/DMJ.2020.0291

[9] Kuchler, J.C., Siqueira, B.S., Ceglarek, V.M., Chasko, F.V., Moura, I.C., Sczepanhak, B.F., Vettorazzi, J.F., Balbo, S.L., Grassiolli, S. (2021) The Vagus Nerve and Spleen: Influence on White Adipose Mass and Histology of Obese and Non-obese Rats
. Journal of Frontiers in Physiology, 12, 751. DOI:10.3389/fphys.2021.672027

[10] Zhao, Q.Y, Yi, X.Y, Wang, Z.H. (2021) Meta-Analysis of the Relationship between Abdominal Obesity and Diabetic Kidney Disease in Type 2 Diabetic Patients. Obesity facts, 14(4), 338-345. https://doi.org/10.37155/2717-5669-0203-2

[11] Zeng, X.L. (2021) Professor HE Xiaohui's Theoretical Research and Clinical Application of "Spleen Hiding Camp" in Neijing. Jiangxi University of Traditional Chinese Medicine.

[12] Fang, B., Ren, Q.L. Ren Qing-ling's treatment of obese polycystic ovary Syndrome based on "Two Yang's disease develops the heart and spleen". Hubei Journal of Traditional Chinese Medicine, 201, 43(05):33-36.

[13] Song, C.M., there were night and sun, Fu Yan, Zhang Jin. Progress of TCM research on obesity. Modern Chinese Medicine, 201, 41(03):6-9. 

[14] Zhang, Z.Y. Research Progress of the Protective Effect of Phospholipid on Obesity-Induced Kidney Injury. Journal of Food Safety and Quality Inspection, 201, 12(08):3147-3152.

[15] Yim, H.E., Yoo, K.H. Obesity and Chronic Kidney Disease: Prevalence, Mechanism, and Management. Clinical and experimental paediatrics. 2021. DOI:10.3345/cep.2021.00108

[16] Li, J.X., Zhang, Y., Li, B., Hao, Y.W., Yin, F., Yu, J.R. Study on the Pathogenesis of "Overwork And Obesity" From The Three Viscera Of Liver, Spleen And Kidney. Global Journal of Traditional Chinese Medicine, 201, 14(04):624-626.

[17] Zhang, K.L., Sun, J., Fan, M.C., Qian, H.F., Ying, H., Li, Y., Wang, L. (2021) Functional Ingredients Present in Whole-Grain Foods as Therapeutic Tools to Counteract Obesity: Effects on Brown And White Adipose Tissues. Trends in Food Science & Technology, 109.

[18] Li, Y., Cheng, N., Xu, J. Clinical Effect of Tonifying Spleen and Kidney In The Treatment of Hypermass and Obesity Polycystic Ovarian Syndrome and Its Influence on Glucose and Lipid Metabolism, Polycystic Changes of Ovary And Uterine Receptivity. Hebei Journal of Traditional Chinese Medicine, 20, 42(10):1476-1481. DOI:10.3969/j.issn.1002-2619.2020.10.008

[19] Johann, K., Cremer, A.L., Fischer, A.W., Heine, M., & Mittag, J. (2019). Thyroid-Hormone-Induced Browning of White Adipose Tissue Does not Contribute to Thermogenesis and Glucose Consumption. Cell Reports, 27(11), 3385-3400.e3. DOI:10.1016/j.celrep.2019.05.054

[20] Deng, X.M., Xie, J.Y., Wang, Z.G., Tang, A.H., Chen, S.H., Chen, L. (2018) Clinical Observation of Sanren Decoction in Treating Obese Type 2 Diabetes Mellitus Complicated with Diabetic Nephropathy. Tianjin Traditional Chinese Medicine, 35(07):491-494. DOI:10.11656/j.issn.1672-1519.2018.07.04

[21] Adilson, G., David, J.P., Felipe, H., Alexander, H. Bedard, E.H., Mark, K., Kamal, R., Donald, A.M., Michael, P.C. (2018) Neuronal Modulation of Brown Adipose Activity Through Perturbation of White Adipocyte Lipogenesis. Journal of Molecular Metabolism, 16, 116-125. DOI:10.1016/j.molmet.2018.06.014

[22] Usui, M., Uno, M., Nishida, E. (2016) Src Family Kinases Suppress Differentiation of Brown Adipocytes and Browning of White Adipocytes. Genes To Cells: Devoted To Molecular & Cellular Mechanisms, 21(4).

[23]Joanna, W., Barbara, J., Anna, K.C.O., Robert, C., Mariusz, M., Micha, C.Z., Odzimierz, B., Piotr, R. (2014) Innervation Pattern of Polycystic Ovaries in the Women. Journal of Chemical Neuroanatomy, 21-62.

[24]Lo, K.Y.A., Sun, L. (2013) Turning WAT into BAT: A Review on Regulators Controlling the Browning of White Adipocytes. Bioscience Reports, 33(5). DOI:10.1016/j.jchemneu.2014.05.003

[25]Reyes, F.M., Fosdomenech, J., Serra, D., Herrero, L., SanchezInfantes, D. (2021) White Adipose Tissue Dysfunction in Obesity and Aging. Biochemical Pharmacology, 192.

[26] Huang, D., Zhang, Z., Dong, Z., Huang, J., Xu, G. (2021) Caloric Restriction and Roux-En-Y Gastric Bypass Promote White Adipose Tissue Browning in Mice. Journal of endocrinological investigation.

[27]Sunita, J.R., Balasaheb, B.G., Jaiprakash, B.R., Milind, H.P., Ravi, R.G., Suyog, S.J. (2013) Clinical Characteristics of Polycystic Ovary Syndrome in Indian Women. Indian Journal of Endocrinology and Metabolism, (1).

[28] Zhang, X., Lian, F. (2002) Research Progress on the Mechanism and Clinical Significance of Inflammatory Cytokines Interleukin-6, Tumor Necrosis Factor-Α and Transforming Growth Factor-Β1 in Polycystic Ovary Syndrome. Chinese Journal of Sex Science, 31(01):47-50.

[29] Jia, Y. J., Wang, Z.X., Wu, C.L., Wang, D.H. Correlation and Clinical Significance of Serum RBP-4, IL-1Β and VEGF in Obese Patients with Polycystic Ovary Syndrome. Chinese Journal of Family Planning, 201, 29(09):1960-1962. DOI:10.3969/j.issn.1004-8189.2021.09.041

[30] Yin, X.Q., Hou, L., Song, X.J., Jin, L. (2017) The Relationship between Nerve Growth Factor and Polycystic Ovary Syndrome and Its Influence on Pregnancy Outcome. Clinical research in China, 30 (03): 382-384. DOI:CNKI:SUN:ZGCK.0.2017-03-030

[31] Chen, B.J., Cheng, L.N., Wang, Y.W., Shi, L.T., Chen, J.L., Li, L., Sun, X. X. (2009) Expression of Nerve Growth Factor and Its Receptor in Granulosa Cells and the Development Of Follicles In Patients With Polycystic Ovary Syndrome. Chinese Journal of Clinical Synthesis, (12):1314-1316.